GlassScriptPhysician profile
Teresann Nickle
NPI 1831245786
$1,295.51
in general payments reported to CMS, 2019-2025
13 companies · $574 in 2025
The $574 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $75.63 · 2023: $14.32 · 2024: $632 · 2025: $574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,171 · Education: $48.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,171.04 |
| Education | $48.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $679.55 | 2024-2025 | Caplyta |
| Neurocrine Biosciences, INC. | $159.92 | 2025 | |
| Abbvie INC. | $90.84 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $66.58 | 2023-2025 | Rexulti, Abilify Asimtufii |
| Corium, LLC | $54.33 | 2024-2025 | Azstarys |
| Lilly USA, LLC | $49.51 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Ironshore Pharmaceuticals INC. | $45.06 | 2024 | |
| Novo Nordisk INC | $42.44 | 2025 | Wegovy |
| Axsome Therapeutics, INC. | $39.46 | 2024-2025 | Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $22.42 | 2025 | |
| Hologic Sales and Service, LLC | $17.31 | 2024 | Aptima |
| Supernus Pharmaceuticals, INC. | $14.41 | 2022 | |
| Exact Sciences Corporation | $13.68 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Teresann Nickle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.